<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fifty patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> had no transfusions of blood products until just before marrow transplantation from HLA-identical family members </plain></SENT>
<SENT sid="1" pm="."><plain>Of the 50, 42 are still alive 1 to 12 years after transplantation (median, 7 years) </plain></SENT>
<SENT sid="2" pm="."><plain>By actuarial standards, the 10-year probability of survival is 82% </plain></SENT>
<SENT sid="3" pm="."><plain>Of the 42 surviving patients, 37 have Karnofsky performance status scores of 100% and 5 with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> have scores ranging from 50% to 90% (median, 80%) </plain></SENT>
<SENT sid="4" pm="."><plain>The 8 <z:hpo ids='HP_0011420'>deaths</z:hpo> were caused by early <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in 1, graft rejection in 1, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> in 3, and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> in 3 </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:hpo ids='HP_0011420'>deaths</z:hpo> occurred within two years after transplantation </plain></SENT>
<SENT sid="6" pm="."><plain>The incidence of graft failure was 10% </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> developed in 14 of 44 patients at risk and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e>, in 15 of 41 </plain></SENT>
<SENT sid="8" pm="."><plain>Risk factors for development of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> included increased age (p = 0.008) and presence of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (p = 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>The only factor associated with increased risk of <z:hpo ids='HP_0011420'>death</z:hpo> was development of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (p = 0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>Results of this study extend our previous finding that patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> who have transplants before the <z:hpo ids='HP_0003674'>onset</z:hpo> of transfusion-induced sensitization have an excellent probability of long-term survival and a <z:mpath ids='MPATH_458'>normal</z:mpath> life </plain></SENT>
</text></document>